Delivery Order SPE2DB20D7059-SPE2DB25FPXP6

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The $4,152.14 firm fixed-price contract has a completion date of May 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,573.48, is for the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. It is a firm fixed-price contract with a completion date of December 2, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $19,410.24 firm-fixed-price contract is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty medication. The delivery order has an ultimate completion date of October 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $42,222.47 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to provide 4,565,425,768 milliliters of the biologic drug ENBREL 50 mg/ml syringes. The contract has an ultimate completion date of August 13, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) Amerisourcebergen holds with the DLA, valued up to $999,999,999 through December 2025, for...
This federal contract award, valued at $13,121.51, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order for the supply of ENBREL 50 MG/ML syringes. The contract has a firm fixed-price pricing type and a completion date of December 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $8,149.88 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 25 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, with a completion date of September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a $11,537.80 firm-fixed price Delivery Order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of ENBREL 50 MG/ML syringes and has a completion date of September 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of essential medical commodities to various federal agencies, including the military. This contract award is part of AmerisourceBergen's...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $61,407.34, is for the supply of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The delivery order has a completion date of August 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, regularly provides a wide range of critical medical commodities, including prescription medications, vaccines, and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,538.68 delivery order contract is for the supply of Enbrel 50 mg/mL syringes. The contract has a firm fixed price and an ultimate completion date of September 29, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICK. The award, valued at $16,111.42, has a firm fixed price and is not designated as a set-aside contract. The ultimate completion date is July 22, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide essential pharmaceutical products and medical supplies to...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPXP6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,579.33, is for the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 9, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/9/25, 9:53 AM